Target Name: TXN2
NCBI ID: G25828
Review Report on TXN2 Target / Biomarker Content of Review Report on TXN2 Target / Biomarker
TXN2
Other Name(s): THIOM_HUMAN | COXPD29 | Trx2 | mitochondrial thioredoxin | Thioredoxin 2 | MTRX | Thioredoxin-2 | Thioredoxin, mitochondrial | TRX2 | Mitochondrial thioredoxin | OTTHUMP00000197898 | MT-TRX | TXN | thioredoxin 2 | Mt-Trx

THIOM-HUMAN: A Potential Drug Target for Alzheimer's and Other Neurological Disorders

THIOM-HUMAN is a protein that is expressed in the brain and has been shown to play a role in various neurological disorders, including Alzheimer's disease. It is also known as TXN2, which stands for Transient X-linked Neuron 2.

THIOM-HUMAN is a protein that is expressed in the brain and has been shown to play a role in various neurological disorders, including Alzheimer's disease. It is also known as TXN2, which stands for Transient X-linked Neuron 2.

Expression of THIOM-HUMAN

THIOM-HUMAN is a protein that is expressed in the brain and has been shown to play a role in various neurological disorders, including Alzheimer's disease. It is expressed in the brain and has been shown to play a role in the development and progression of these disorders.

THIOM-HUMAN is a member of the neurotrophic factor family, which is a group of proteins that are involved in the support and maintenance of neural cells. It is thought to work by promoting the survival and growth of neurons, and by modulating the activity of other proteins that are involved in the development and progression of neurological disorders.

Expression of THIOM-HUMAN in disease

THIOM-HUMAN is a protein that is expressed in the brain and has been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease. It is expressed in the brain and has been shown to contribute to the development and progression of these disorders.

One of the most promising findings about THIOM-HUMAN is its potential as a drug target. THIOM-HUMAN has been shown to interact with a variety of molecules, including beta-amyloid, which is a hallmark of Alzheimer's disease.

Thus, THIOM-HUMAN may be a useful drug target for the treatment of Alzheimer's disease and other neurological disorders. Further research is needed to fully understand the role of THIOM-HUMAN in these disorders and to develop effective treatments.

Conclusion

THIOM-HUMAN is a protein that is expressed in the brain and has been shown to play a role in various neurological disorders, including Alzheimer's disease. It is also known as TXN2, which stands for Transient X-linked Neuron 2.

THIOM-HUMAN is a member of the neurotrophic factor family, which is a group of proteins that are involved in the support and maintenance of neural cells. It is thought to work by promoting the survival and growth of neural cells and by modulating the activity of other proteins that are involved in the development and progression of neurological disorders.

THIOM-HUMAN is a potential drug target for the treatment of Alzheimer's disease and other neurological disorders. Further research is needed to fully understand the role of THIOM-HUMAN in these disorders and to develop effective treatments.

Protein Name: Thioredoxin 2

Functions: Important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability. Possesses a dithiol-reducing activity

The "TXN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TXN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TXNDC11 | TXNDC12 | TXNDC15 | TXNDC16 | TXNDC17 | TXNDC2 | TXNDC5 | TXNDC8 | TXNDC9 | TXNIP | TXNL1 | TXNL1P1 | TXNL4A | TXNL4B | TXNP6 | TXNRD1 | TXNRD2 | TXNRD3 | TXNRD3NB | TYK2 | TYMP | TYMS | TYMSOS | Type II Transmembrane serine protease | TYR | TYRO3 | TYRO3P | TYROBP | Tyrosine Kinase | Tyrosine-Protein Kinase ABL | Tyrosine-Protein Kinases Src | Tyrosyl-DNA phosphodiesterase TDP | TYRP1 | TYSND1 | TYW1 | TYW1B | TYW3 | U2 small nuclear ribonucleoprotein auxiliary factor | U2AF1 | U2AF1L4 | U2AF2 | U2SURP | U3 small nucleolar ribonucleoprotein (U3 snoRNP) complex | U5 small nuclear ribonucleoprotein complex | U7 snRNP complex | UACA | UAP1 | UAP1L1 | UBA1 | UBA2 | UBA3 | UBA5 | UBA52 | UBA52P1 | UBA6 | UBA6-DT | UBA7 | UBAC1 | UBAC2 | UBAC2-AS1 | UBALD1 | UBALD2 | UBAP1 | UBAP1L | UBAP2 | UBAP2L | UBASH3A | UBASH3B | UBB | UBBP1 | UBBP2 | UBBP4 | UBC | UBD | UBDP1 | UBE2A | UBE2B | UBE2C | UBE2CP3 | UBE2CP4 | UBE2D1 | UBE2D2 | UBE2D3 | UBE2D3P1 | UBE2D4 | UBE2DNL | UBE2E1 | UBE2E2 | UBE2E3 | UBE2F | UBE2F-SCLY | UBE2FP1 | UBE2G1 | UBE2G2 | UBE2H | UBE2HP1 | UBE2I | UBE2J1 | UBE2J2 | UBE2K